Neuphoria Therapeutics (NEUP) Stock Price
Neuphoria Therapeutics Price
Over the last 19 years Neuphoria Therapeutics grew revenue by 6.7% annually, reaching 15.65 M USD. For Neuphoria Therapeutics, the net margin of -2.4% is up versus -634.4% a few years ago. The consensus 12-month price target for Neuphoria Therapeutics is 7.14 USD, about 114.4% above where the stock trades today. Of 9 analysts, 7 rate the stock a buy — an overall Buy consensus.
Neuphoria Therapeutics stock price
Neuphoria Therapeutics business model & stock analysis
Frequently asked questions about Neuphoria Therapeutics
Analysts currently set an average price target of 9.96 USD for the Neuphoria Therapeutics stock (median: 7.14 USD), implying +199.2 % versus the latest price. The consensus is based on 9 analyst ratings.
6 analysts currently rate the Neuphoria Therapeutics stock: 0 recommend buying, 3 holding and 3 selling. For 2026, analysts expect Neuphoria Therapeutics to generate revenue of 9.44 M USD and earnings per share of -13.49 USD.
Converted at the current exchange rate, the Neuphoria Therapeutics share trades at 2.97 EUR (3.33 USD).
The expected revenue of Neuphoria Therapeutics is 9.44 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Neuphoria Therapeutics is -21.90 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Neuphoria Therapeutics is currently -0.25. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Neuphoria Therapeutics stock.
The price-to-sales ratio (P/S) of Neuphoria Therapeutics is currently 0.57. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Neuphoria Therapeutics stock.
The Eulerpool Quality Score for Neuphoria Therapeutics is 3/10.
The ISIN of Neuphoria Therapeutics is US64136E1029. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Neuphoria Therapeutics is NEUP. The ticker symbol is used to trade Neuphoria Therapeutics shares on the stock exchange.
Neuphoria Therapeutics stock
Neuphoria Therapeutics Peer Group
All fundamentals and in-depth analysis of Neuphoria Therapeutics
Our stock analysis for Neuphoria Therapeutics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Neuphoria Therapeutics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.